Jazz Pharmaceuticals plc (JAZZ)
USD 110.51
(-8.54%)
USD 110.51
(-8.54%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 4.59 Billion USD | -6.6% |
| 2022 | 4.91 Billion USD | -11.38% |
| 2021 | 5.54 Billion USD | 371.13% |
| 2020 | 1.17 Billion USD | 4.99% |
| 2019 | 1.12 Billion USD | -12.87% |
| 2018 | 1.28 Billion USD | 7.68% |
| 2017 | 1.19 Billion USD | -28.17% |
| 2016 | 1.66 Billion USD | 671.22% |
| 2015 | 215.71 Million USD | -67.24% |
| 2014 | 658.38 Million USD | 860.89% |
| 2013 | -86.52 Million USD | -224.38% |
| 2012 | 69.56 Million USD | 184.76% |
| 2011 | -82.07 Million USD | -2626.19% |
| 2010 | 3.24 Million USD | -97.01% |
| 2009 | 108.67 Million USD | 11.45% |
| 2008 | 97.5 Million USD | 500.11% |
| 2007 | -24.37 Million USD | -885.04% |
| 2006 | -2.47 Million USD | -104.67% |
| 2005 | 53.01 Million USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | 4.49 Billion USD | -1.23% |
| 2024 Q1 | 4.55 Billion USD | -0.84% |
| 2023 Q4 | 4.59 Billion USD | 2.96% |
| 2023 Q2 | 4.51 Billion USD | -2.31% |
| 2023 Q1 | 4.62 Billion USD | -5.9% |
| 2023 Q3 | 4.45 Billion USD | -1.32% |
| 2023 FY | 4.59 Billion USD | -6.6% |
| 2022 Q4 | 4.91 Billion USD | -1.22% |
| 2022 Q2 | 5.4 Billion USD | -4.07% |
| 2022 FY | 4.91 Billion USD | -11.38% |
| 2022 Q1 | 5.63 Billion USD | 1.56% |
| 2022 Q3 | 4.97 Billion USD | -7.92% |
| 2021 Q3 | 5.71 Billion USD | -5.16% |
| 2021 Q2 | 6.02 Billion USD | 3807.05% |
| 2021 FY | 5.54 Billion USD | 371.13% |
| 2021 Q1 | 154.18 Million USD | -86.9% |
| 2021 Q4 | 5.54 Billion USD | -2.93% |
| 2020 Q2 | 1.46 Billion USD | 36.79% |
| 2020 Q1 | 1.06 Billion USD | -4.72% |
| 2020 Q4 | 1.17 Billion USD | -21.57% |
| 2020 Q3 | 1.5 Billion USD | 2.7% |
| 2020 FY | 1.17 Billion USD | 4.99% |
| 2019 Q3 | 974.14 Million USD | -13.01% |
| 2019 Q4 | 1.12 Billion USD | 15.09% |
| 2019 FY | 1.12 Billion USD | -12.87% |
| 2019 Q1 | 1.21 Billion USD | -5.66% |
| 2019 Q2 | 1.11 Billion USD | -7.76% |
| 2018 Q4 | 1.28 Billion USD | 17.52% |
| 2018 Q2 | 1.1 Billion USD | -1.98% |
| 2018 Q1 | 1.12 Billion USD | -5.52% |
| 2018 FY | 1.28 Billion USD | 7.68% |
| 2018 Q3 | 1.09 Billion USD | -1.05% |
| 2017 Q3 | 1.32 Billion USD | -7.36% |
| 2017 Q2 | 1.43 Billion USD | -6.28% |
| 2017 FY | 1.19 Billion USD | -28.17% |
| 2017 Q1 | 1.52 Billion USD | -8.11% |
| 2017 Q4 | 1.19 Billion USD | -9.97% |
| 2016 Q1 | 204.24 Million USD | -5.32% |
| 2016 FY | 1.66 Billion USD | 671.22% |
| 2016 Q4 | 1.66 Billion USD | -8.43% |
| 2016 Q3 | 1.81 Billion USD | 483.86% |
| 2016 Q2 | 311.18 Million USD | 52.36% |
| 2015 Q1 | 561.44 Million USD | -14.72% |
| 2015 FY | 215.71 Million USD | -67.24% |
| 2015 Q2 | 444.82 Million USD | -20.77% |
| 2015 Q3 | 290.83 Million USD | -34.62% |
| 2015 Q4 | 215.71 Million USD | -25.83% |
| 2014 FY | 658.38 Million USD | 860.89% |
| 2014 Q4 | 658.38 Million USD | -14.02% |
| 2014 Q3 | 765.74 Million USD | -17.5% |
| 2014 Q2 | 928.17 Million USD | -2.58% |
| 2014 Q1 | 952.73 Million USD | 1201.07% |
| 2013 Q3 | -37.32 Million USD | -177.78% |
| 2013 FY | -86.52 Million USD | -224.38% |
| 2013 Q4 | -86.52 Million USD | -131.82% |
| 2013 Q2 | 47.98 Million USD | 7271.58% |
| 2013 Q1 | 651 Thousand USD | -99.06% |
| 2012 FY | 69.56 Million USD | 184.76% |
| 2012 Q4 | 69.56 Million USD | -74.48% |
| 2012 Q1 | -170.65 Million USD | -107.92% |
| 2012 Q2 | 313.39 Million USD | 283.64% |
| 2012 Q3 | 272.55 Million USD | -13.03% |
| 2011 Q3 | -101.21 Million USD | -54.05% |
| 2011 FY | -82.07 Million USD | -2626.19% |
| 2011 Q1 | -24.36 Million USD | -849.8% |
| 2011 Q2 | -65.7 Million USD | -169.71% |
| 2011 Q4 | -82.07 Million USD | 18.91% |
| 2010 Q3 | 13.2 Million USD | -66.19% |
| 2010 FY | 3.24 Million USD | -97.01% |
| 2010 Q2 | 39.04 Million USD | -61.55% |
| 2010 Q1 | 101.55 Million USD | -6.55% |
| 2010 Q4 | 3.24 Million USD | -75.39% |
| 2009 FY | 108.67 Million USD | 11.45% |
| 2009 Q4 | 108.67 Million USD | 2.39% |
| 2009 Q3 | 106.13 Million USD | -6.66% |
| 2009 Q2 | 113.71 Million USD | -3.32% |
| 2009 Q1 | 117.61 Million USD | 20.62% |
| 2008 Q3 | 66.97 Million USD | -2.37% |
| 2008 Q4 | 97.5 Million USD | 45.59% |
| 2008 Q2 | 68.6 Million USD | 334.84% |
| 2008 FY | 97.5 Million USD | 500.11% |
| 2008 Q1 | 15.77 Million USD | 164.74% |
| 2007 Q4 | -24.37 Million USD | 42.68% |
| 2007 Q1 | 9.86 Million USD | 498.79% |
| 2007 Q2 | -70.24 Million USD | -811.98% |
| 2007 Q3 | -42.51 Million USD | 39.48% |
| 2007 FY | -24.37 Million USD | -885.04% |
| 2006 FY | -2.47 Million USD | -104.67% |
| 2006 Q4 | -2.47 Million USD | 0.0% |
| 2005 Q4 | 53.01 Million USD | 0.0% |
| 2005 FY | 53.01 Million USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| AbCellera Biologics Inc. | -55.94 Million USD | 8305.833% |
| Alkermes plc | -166.73 Million USD | 2853.011% |
| Agenus Inc. | 274.13 Million USD | -1574.477% |
| Alnylam Pharmaceuticals, Inc. | 1.86 Billion USD | -145.481% |
| Aptorum Group Limited | 1.35 Million USD | -338159.941% |
| Ardelyx, Inc. | 34.51 Million USD | -13200.716% |
| Arrowhead Pharmaceuticals, Inc. | 4.28 Million USD | -107151.005% |
| Bicycle Therapeutics plc | -481.46 Million USD | 1053.408% |
| BioXcel Therapeutics, Inc. | 36.16 Million USD | -12593.48% |
| ChromaDex Corporation | -24.04 Million USD | 19188.253% |
| Chimerix, Inc. | -25.51 Million USD | 18089.352% |
| Corbus Pharmaceuticals Holdings, Inc. | 6.96 Million USD | -65776.764% |
| Caribou Biosciences, Inc. | -23.67 Million USD | 19487.351% |
| CRISPR Therapeutics AG | -150.84 Million USD | 3143.086% |
| Precision BioSciences, Inc. | -85.41 Million USD | 5474.48% |
| Dyadic International, Inc. | -6.37 Million USD | 72070.394% |
| Eton Pharmaceuticals, Inc. | -15.93 Million USD | 28910.287% |
| Fortress Biotech, Inc. | 7.66 Million USD | -59787.058% |
| Lantern Pharma Inc. | -21.7 Million USD | 21250.459% |
| HOOKIPA Pharma Inc. | -110.53 Million USD | 4252.766% |
| Inhibikase Therapeutics, Inc. | -8.54 Million USD | 53831.107% |
| Incyte Corporation | -3.17 Billion USD | 244.574% |
| IO Biotech, Inc. | -140.69 Million USD | 3362.527% |
| Jaguar Health, Inc. | 29.39 Million USD | -15518.193% |
| Novavax, Inc. | -298.29 Million USD | 1638.865% |
| Janux Therapeutics, Inc. | 5.33 Million USD | -85909.8% |
| Opthea Limited | 28.15 Million USD | -16202.413% |
| Ligand Pharmaceuticals Incorporated | -16.78 Million USD | 27441.372% |
| ContextLogic Inc. | -232 Million USD | 2078.596% |
| MiMedx Group, Inc. | -33.9 Million USD | 13640.435% |
| Pyxis Oncology, Inc. | 10.19 Million USD | -44925.434% |
| TransCode Therapeutics, Inc. | -2.31 Million USD | 198213.488% |
| NextCure, Inc. | -6.47 Million USD | 70971.437% |
| Ocuphire Pharma, Inc. | -50.5 Million USD | 9189.608% |
| Oncternal Therapeutics, Inc. | -6.37 Million USD | 72060.229% |
| Outlook Therapeutics, Inc. | 12.16 Million USD | -37639.392% |
| Vaxcyte, Inc. | -368.22 Million USD | 1346.607% |
| PDS Biotechnology Corporation | -32.7 Million USD | 14133.927% |
| Madrigal Pharmaceuticals, Inc. | 17.27 Million USD | -26467.56% |
| Pharming Group N.V. | 109.8 Million USD | -4080.488% |
| Pieris Pharmaceuticals, Inc. | -17.39 Million USD | 26487.348% |
| Avidity Biosciences, Inc. | -175.23 Million USD | 2719.61% |
| Reviva Pharmaceuticals Holdings, Inc. | -18.51 Million USD | 24886.062% |
| Reviva Pharmaceuticals Holdings, Inc. | -18.51 Million USD | 24886.062% |
| Sangamo Therapeutics, Inc. | -7.1 Million USD | 64752.718% |
| Sol-Gel Technologies Ltd. | -5.86 Million USD | 78433.498% |
| Acelyrin, Inc. | -216.9 Million USD | 2216.311% |
| Salarius Pharmaceuticals, Inc. | -5.61 Million USD | 81920.402% |
| SELLAS Life Sciences Group, Inc. | -1.72 Million USD | 266361.195% |
| Summit Therapeutics Inc. | 34.67 Million USD | -13138.574% |
| Sensei Biotherapeutics, Inc. | -6.8 Million USD | 67575.276% |
| Senti Biosciences, Inc. | 1.74 Million USD | -263712.816% |
| Stoke Therapeutics, Inc. | -184.6 Million USD | 2586.549% |
| Syros Pharmaceuticals, Inc. | -77.45 Million USD | 6026.77% |
| Alaunos Therapeutics, Inc. | -6.06 Million USD | 75823.243% |
| Telomir Pharmaceuticals, Inc. Common Stock | 99.76 Thousand USD | -4600871.244% |
| Entrada Therapeutics, Inc. | 628 Thousand USD | -730846.338% |
| VistaGen Therapeutics, Inc. | -117.04 Million USD | 4021.828% |
| Wave Life Sciences Ltd. | -168.23 Million USD | 2828.563% |
| Sorrento Therapeutics, Inc. | 110.87 Million USD | -4040.293% |
| TRACON Pharmaceuticals, Inc. | -7.59 Million USD | 60531.056% |
| Barinthus Biotherapeutics plc | -129.11 Million USD | 3655.264% |
| Psyence Biomedical Ltd. | 6.89 Million USD | -66478.835% |
| Phathom Pharmaceuticals, Inc. | -242.36 Million USD | 1993.995% |
| Immix Biopharma, Inc. | -17.5 Million USD | 26315.864% |
| Keros Therapeutics, Inc. | -316.7 Million USD | 1549.416% |
| MEI Pharma, Inc. | -3.7 Million USD | 123995.897% |
| Windtree Therapeutics, Inc. | 12.51 Million USD | -36590.456% |
| Xeris Biopharma Holdings, Inc. | 161.74 Million USD | -2738.065% |
| Rigel Pharmaceuticals, Inc. | 27.79 Million USD | -16416.184% |
| Fortress Biotech, Inc. | 7.66 Million USD | -59787.058% |
| Precigen, Inc. | -481 Thousand USD | 954433.264% |
| Clearside Biomedical, Inc. | 14.08 Million USD | -32499.553% |
| AlloVir, Inc. | -62.69 Million USD | 7422.055% |
| C4 Therapeutics, Inc. | -55.61 Million USD | 8353.934% |
| Fate Therapeutics, Inc. | 61.66 Million USD | -7343.88% |
| ImmuCell Corporation | 10.99 Million USD | -41666.226% |
| IDEAYA Biosciences, Inc. | -154.14 Million USD | 3077.919% |
| Onconetix, Inc. | 5.33 Million USD | -85999.545% |
| PureTech Health plc | -167.19 Million USD | 2845.47% |
| VYNE Therapeutics Inc. | -30.46 Million USD | 15170.069% |
| Elevation Oncology, Inc. | -19.11 Million USD | 24110.582% |
| Kintara Therapeutics, Inc. | -4.9 Million USD | 93608.719% |
| Seer, Inc. | -4.24 Million USD | 108362.807% |
| Verrica Pharmaceuticals Inc. | -24.03 Million USD | 19196.988% |
| Innoviva, Inc. | 255.56 Million USD | -1696.169% |
| Aadi Bioscience, Inc. | -55.86 Million USD | 8316.997% |
| ESSA Pharma Inc. | -33.62 Million USD | 13752.965% |
| GlycoMimetics, Inc. | -40.98 Million USD | 11300.212% |
| GT Biopharma, Inc. | -1.02 Million USD | 449692.85% |
| Inhibrx Biosciences, Inc. | -67.78 Million USD | 6872.115% |
| Akebia Therapeutics, Inc. | 61.25 Million USD | -7393.581% |
| Catalyst Pharmaceuticals, Inc. | -134.07 Million USD | 3523.611% |
| Longboard Pharmaceuticals, Inc. | -13.85 Million USD | 33228.919% |
| Orchestra BioMed Holdings, Inc. | -28.87 Million USD | 15998.944% |
| Alzamend Neuro, Inc. | -75.33 Thousand USD | 6093421.741% |
| Rocket Pharmaceuticals, Inc. | -30.86 Million USD | 14973.77% |
| Aptose Biosciences Inc. | -8.19 Million USD | 56114.925% |
| ZyVersa Therapeutics, Inc. | -3.12 Million USD | 146802.352% |
| Soligenix, Inc. | -4.95 Million USD | 92804.293% |
| Century Therapeutics, Inc. | 847 Thousand USD | -541853.129% |
| Kura Oncology, Inc. | -20.11 Million USD | 22917.094% |
| TScan Therapeutics, Inc. | -40.92 Million USD | 11316.202% |
| Intensity Therapeutics, Inc. | -8.39 Million USD | 54759.955% |
| Ocean Biomedical, Inc. | 1.82 Million USD | -251881.973% |
| CytomX Therapeutics, Inc. | -3.19 Million USD | 143682.828% |
| Autolus Therapeutics plc | -186.59 Million USD | 2560.004% |
| Mineralys Therapeutics, Inc. | -49.3 Million USD | 9410.285% |
| EyePoint Pharmaceuticals, Inc. | -275.79 Million USD | 1764.41% |
| Eterna Therapeutics Inc. | 34.26 Million USD | -13295.421% |
| Adaptive Biotechnologies Corporation | 164.36 Million USD | -2692.723% |
| GRI Bio, Inc. | -1.79 Million USD | 255971.962% |
| Xenetic Biosciences, Inc. | -8.98 Million USD | 51200.072% |
| Tenaya Therapeutics, Inc. | -33.25 Million USD | 13902.637% |
| IGM Biosciences, Inc. | -72.6 Million USD | 6422.264% |
| INmune Bio, Inc. | -25.41 Million USD | 18164.393% |
| Heron Therapeutics, Inc. | 150.95 Million USD | -2940.949% |
| SAB Biotherapeutics, Inc. | -50.65 Million USD | 9161.257% |
| Pasithea Therapeutics Corp. | -16.24 Million USD | 28349.356% |
| Entero Therapeutics, Inc. | -2.88 Million USD | 159214.757% |
| Milestone Pharmaceuticals Inc. | 38.01 Million USD | -11975.084% |
| X4 Pharmaceuticals, Inc. | -41.18 Million USD | 11245.667% |
| Atara Biotherapeutics, Inc. | 31.88 Million USD | -14296.56% |
| Coherus BioSciences, Inc. | 377.95 Million USD | -1114.534% |
| Verastem, Inc. | -37.27 Million USD | 12413.812% |
| Abeona Therapeutics Inc. | -9.07 Million USD | 50693.442% |
| Pliant Therapeutics, Inc. | -51.86 Million USD | 8951.072% |
| Tonix Pharmaceuticals Holding Corp. | -15.13 Million USD | 30429.323% |
| Histogen Inc. | -7.48 Million USD | 61410.845% |
| Aprea Therapeutics, Inc. | -21.6 Million USD | 21344.88% |
| Surrozen, Inc. | -32.66 Million USD | 14153.218% |
| Organovo Holdings, Inc. | -1.5 Million USD | 304701.393% |
| Lixte Biotechnology Holdings, Inc. | -4.2 Million USD | 109303.19% |
| Ovid Therapeutics Inc. | 18.96 Million USD | -24110.404% |
| Panbela Therapeutics, Inc. | 2.61 Million USD | -175371.827% |
| CASI Pharmaceuticals, Inc. | 4.15 Million USD | -110350.987% |
| Cadrenal Therapeutics, Inc. Common Stock | -8.38 Million USD | 54869.847% |
| Centessa Pharmaceuticals plc | -43.44 Million USD | 10666.601% |
| Hepion Pharmaceuticals, Inc. | -14.57 Million USD | 31590.616% |
| Arcturus Therapeutics Holdings Inc. | -316.78 Million USD | 1549.022% |
| BioRestorative Therapies, Inc. | -722.06 Thousand USD | 635828.748% |
| Apollomics, Inc. | -27.39 Million USD | 16856.134% |
| Amarin Corporation plc | -191.04 Million USD | 2502.818% |
| Mesoblast Limited | 55.96 Million USD | -8102.461% |
| Turnstone Biologics Corp. | -14.58 Million USD | 31575.199% |
| Kymera Therapeutics, Inc. | -25.29 Million USD | 18249.387% |
| Synaptogenix, Inc. | -28.66 Million USD | 16115.712% |
| Tiziana Life Sciences Ltd | -936 Thousand USD | 490521.261% |
| Aurinia Pharmaceuticals Inc. | 48.73 Million USD | -9319.566% |
| BriaCell Therapeutics Corp. | -862.08 Thousand USD | 532567.413% |
| Monopar Therapeutics Inc. | -7.26 Million USD | 63274.958% |
| Exelixis, Inc. | -73.05 Million USD | 6383.837% |
| Better Therapeutics, Inc. | -860 Thousand USD | 533860.814% |
| Nurix Therapeutics, Inc. | -24.01 Million USD | 19216.075% |
| Apellis Pharmaceuticals, Inc. | -241.37 Million USD | 2001.779% |
| NLS Pharmaceutics AG | 736.06 Thousand USD | -623531.984% |
| Dermata Therapeutics, Inc. | -7.43 Million USD | 61813.628% |
| Aridis Pharmaceuticals, Inc. | 1.25 Million USD | -365956.061% |
| Gritstone bio, Inc. | 39.49 Million USD | -11524.064% |
| Jasper Therapeutics, Inc. | -84.1 Million USD | 5558.131% |
| TNF Pharmaceuticals, Inc. | -2.63 Million USD | 174495.853% |
| Avid Bioservices, Inc. | 169.72 Million USD | -2604.529% |
| Insmed Incorporated | 721.62 Million USD | -536.116% |
| Virpax Pharmaceuticals, Inc. | -9.14 Million USD | 50314.264% |
| MediWound Ltd. | -5.32 Million USD | 86352.217% |
| OmniAb, Inc. | 9.2 Million USD | -49778.768% |
| Alector, Inc. | -35.63 Million USD | 12980.835% |
| Seres Therapeutics, Inc. | 85.97 Million USD | -5239.409% |
| Checkpoint Therapeutics, Inc. | -4.92 Million USD | 93248.194% |
| Viracta Therapeutics, Inc. | 13.23 Million USD | -34572.883% |
| Zai Lab Limited | -775 Million USD | 692.302% |
| Revance Therapeutics, Inc. | 340.55 Million USD | -1247.901% |
| Aura Biosciences, Inc. | -21.52 Million USD | 21425.635% |
| Lyell Immunopharma, Inc. | -82.48 Million USD | 5665.401% |
| Immunic, Inc. | -45.34 Million USD | 10224.268% |
| Tarsus Pharmaceuticals, Inc. | -193.21 Million USD | 2475.769% |
| Veracyte, Inc. | -203.82 Million USD | 2352.111% |
| InMed Pharmaceuticals Inc. | 638.29 Million USD | -619.159% |
| FibroGen, Inc. | 56.76 Million USD | -7986.288% |
| SeaStar Medical Holding Corporation | 8.9 Million USD | -51447.928% |
| Adial Pharmaceuticals, Inc. | -2.82 Million USD | 162470.352% |
| Sonnet BioTherapeutics Holdings, Inc. | -2.07 Million USD | 221818.426% |
| Cyclacel Pharmaceuticals, Inc. | -3.34 Million USD | 137494.283% |
| Amylyx Pharmaceuticals, Inc. | -165.96 Million USD | 2865.867% |
| TG Therapeutics, Inc. | 17.86 Million USD | -25598.931% |
| Galecto, Inc. | -21.21 Million USD | 21736.232% |
| Calithera Biosciences, Inc. | -23.78 Million USD | 19399.319% |
| Fortrea Holdings Inc. | 1.56 Billion USD | -192.49% |
| KalVista Pharmaceuticals, Inc. | -24.47 Million USD | 18857.531% |
| Aptevo Therapeutics Inc. | -11.5 Million USD | 39991.744% |
| XBiotech Inc. | -200.02 Million USD | 2394.908% |
| Jasper Therapeutics, Inc. | -84.1 Million USD | 5558.131% |
| Lyra Therapeutics, Inc. | 4.52 Million USD | -101276.833% |
| Foghorn Therapeutics Inc. | -35.26 Million USD | 13117.449% |
| Y-mAbs Therapeutics, Inc. | -77.21 Million USD | 6044.654% |
| Theravance Biopharma, Inc. | 5.69 Million USD | -80559.691% |
| Ultragenyx Pharmaceutical Inc. | -170.41 Million USD | 2793.626% |
| Metagenomi, Inc. Common Stock | -92.37 Million USD | 5069.302% |
| Vaxxinity, Inc. | 10.13 Million USD | -45205.399% |
| BioCryst Pharmaceuticals, Inc. | 736.26 Million USD | -523.463% |
| Gain Therapeutics, Inc. | -10.76 Million USD | 42731.263% |
| Cartesian Therapeutics, Inc. | -65.95 Million USD | 7059.705% |
| NexImmune, Inc. | -3.13 Million USD | 146585.831% |
| Creative Medical Technology Holdings, Inc. | -3.45 Million USD | 133050.413% |
| Marker Therapeutics, Inc. | -15.11 Million USD | 30476.589% |
| Regeneron Pharmaceuticals, Inc. | -27.1 Million USD | 17038.535% |
| Chemomab Therapeutics Ltd. | -8.97 Million USD | 51239.883% |
| Scopus BioPharma Inc. | -124.57 Thousand USD | 3684902.729% |
| RAPT Therapeutics, Inc. | -40.57 Million USD | 11414.066% |
| Ainos, Inc. | 4.07 Million USD | -112465.573% |
| Pluri Inc. | 22.82 Million USD | -20007.508% |
| Prothena Corporation plc | -608.34 Million USD | 854.56% |
| Adaptimmune Therapeutics plc | -118.75 Million USD | 3965.357% |
| Celularity Inc. | 65.19 Million USD | -6941.483% |
| Rallybio Corporation | -24.1 Million USD | 19145.486% |
| Cue Biopharma, Inc. | -33.81 Million USD | 13673.267% |
| MeiraGTx Holdings plc | -40.3 Million USD | 11489.864% |
| Omeros Corporation | 331.17 Million USD | -1286.074% |
| Humacyte, Inc. | -22.48 Million USD | 20514.227% |
| Immunocore Holdings plc | -358.59 Million USD | 1380.095% |
| Cocrystal Pharma, Inc. | -24.57 Million USD | 18778.914% |
| Cidara Therapeutics, Inc. | -30.9 Million USD | 14954.998% |
| Blueprint Medicines Corporation | 702.83 Million USD | -553.117% |
| CalciMedica, Inc. | -5.53 Million USD | 83108.011% |
| Cabaletta Bio, Inc. | -188.22 Million USD | 2538.818% |
| Marinus Pharmaceuticals, Inc. | -10.21 Million USD | 45041.678% |
| Scholar Rock Holding Corporation | -40.03 Million USD | 11565.252% |
| Sana Biotechnology, Inc. | -33.25 Million USD | 13904.297% |
| Pulmatrix, Inc. | -10.41 Million USD | 44165.883% |
| Elicio Therapeutics, Inc. | -5.97 Million USD | 76900.117% |
| Vigil Neuroscience, Inc. | -38.14 Million USD | 12134.878% |
| Intellia Therapeutics, Inc. | -111.4 Million USD | 4220.521% |
| Adlai Nortye Ltd. American Depositary Shares | -59.94 Million USD | 7757.717% |
| Cytokinetics, Incorporated | 642.37 Million USD | -614.593% |
| Eloxx Pharmaceuticals, Inc. | -5.82 Million USD | 78931.238% |
| Nutriband Inc. | -251.65 Thousand USD | 1824147.414% |
| Protara Therapeutics, Inc. | -34.11 Million USD | 13553.92% |
| Vor Biopharma Inc. | 4.3 Million USD | -106652.163% |
| Roivant Sciences Ltd. | -6.03 Billion USD | 176.05% |
| Evogene Ltd. | -19.63 Million USD | 23479.561% |
| ProKidney Corp. | -56.23 Million USD | 8262.641% |
| Applied Therapeutics, Inc. | -48.67 Million USD | 9531.178% |
| Hoth Therapeutics, Inc. | -9.23 Million USD | 49794.166% |
| BridgeBio Pharma, Inc. | 1.36 Billion USD | -236.559% |
| CorMedix Inc. | -43.05 Million USD | 10762.197% |
| BioLineRx Ltd. | 7.33 Million USD | -62472.833% |
| Tango Therapeutics, Inc. | -27.46 Million USD | 16813.428% |
| Galectin Therapeutics Inc. | 46.14 Million USD | -9847.219% |
| Atai Life Sciences N.V. | -28.55 Million USD | 16173.755% |
| Renovaro Biosciences Inc. | 2.23 Million USD | -205696.159% |
| Aerovate Therapeutics, Inc. | -22.81 Million USD | 20218.965% |
| Zentalis Pharmaceuticals, Inc. | 17.73 Million USD | -25782.96% |
| Sagimet Biosciences Inc. | -75.07 Million USD | 6214.424% |
| MediciNova, Inc. | -50.78 Million USD | 9139.041% |
| Praxis Precision Medicines, Inc. | -78.8 Million USD | 5924.939% |
| Cardio Diagnostics Holdings, Inc. | -22.49 Thousand USD | 20406159.124% |
| GeoVax Labs, Inc. | -6.45 Million USD | 71239.553% |
| Axsome Therapeutics, Inc. | -199.82 Million USD | 2397.228% |
| Biomea Fusion, Inc. | -166.57 Million USD | 2855.804% |
| PTC Therapeutics, Inc. | -178.97 Million USD | 2664.796% |
| Mereo BioPharma Group plc | -51.46 Million USD | 9018.656% |
| Cullinan Oncology, Inc. | -94.84 Million USD | 4939.888% |
| Syndax Pharmaceuticals, Inc. | -293.75 Million USD | 1662.622% |
| Absci Corporation | -72.59 Million USD | 6422.961% |
| NRx Pharmaceuticals, Inc. | 4.56 Million USD | -100433.136% |
| 4D Molecular Therapeutics, Inc. | -234.43 Million USD | 2058.028% |
| Dyne Therapeutics, Inc. | -94.21 Million USD | 4972.407% |
| Kiniksa Pharmaceuticals, Ltd. | -95.69 Million USD | 4896.797% |
| Ventyx Biosciences, Inc. | -39.07 Million USD | 11848.12% |
| Allakos Inc. | -24.97 Million USD | 18479.752% |
| Imunon, Inc. | -4.21 Million USD | 109034.604% |
| Fulcrum Therapeutics, Inc. | -14.74 Million USD | 31237.858% |
| Corcept Therapeutics Incorporated | -135.4 Million USD | 3490.209% |
| BioAtla, Inc. | -109.01 Million USD | 4310.899% |
| NLS Pharmaceutics AG | 736.06 Thousand USD | -623531.984% |
| Bio-Path Holdings, Inc. | -939 Thousand USD | 488954.42% |
| Allogene Therapeutics, Inc. | 11.96 Million USD | -38261.549% |
| Larimar Therapeutics, Inc. | -21.2 Million USD | 21749.498% |
| XOMA Corporation | -29 Million USD | 15928.769% |
| Kezar Life Sciences, Inc. | -16.56 Million USD | 27819.463% |
| Cara Therapeutics, Inc. | -9.01 Million USD | 51013.299% |
| aTyr Pharma, Inc. | -7.44 Million USD | 61723.614% |
| Aligos Therapeutics, Inc. | -124.63 Million USD | 3782.999% |
| Akero Therapeutics, Inc. | -208.16 Million USD | 2305.157% |
| Viridian Therapeutics, Inc. | -81.77 Million USD | 5713.107% |
| Eliem Therapeutics, Inc. | -92.76 Million USD | 5048.463% |
| EyeGate Pharmaceuticals, Inc. | -859.18 Thousand USD | 534367.747% |
| Akari Therapeutics, Plc | -3.84 Million USD | 119484.733% |
| Tevogen Bio Holdings Inc. | 1.62 Million USD | -282749.916% |
| Halozyme Therapeutics, Inc. | 1.38 Billion USD | -232.422% |
| Lexaria Bioscience Corp. | -1.18 Million USD | 386448.605% |
| UroGen Pharma Ltd. | 4.39 Million USD | -104439.809% |
| Sutro Biopharma, Inc. | 113.48 Million USD | -3945.032% |
| ZIVO Bioscience, Inc. | 71.96 Thousand USD | -6378743.0% |
| Orgenesis Inc. | 21.78 Million USD | -20972.085% |
| Entera Bio Ltd. | -10.62 Million USD | 43286.97% |
| GH Research PLC | -78.07 Million USD | 5979.251% |
| Lisata Therapeutics, Inc. | -22.28 Million USD | 20695.581% |
| Reneo Pharmaceuticals, Inc. | -26.65 Million USD | 17318.737% |
| Xencor, Inc. | 29.64 Million USD | -15384.897% |
| 60 Degrees Pharmaceuticals, Inc. | -1.96 Million USD | 233134.574% |
| Replimune Group, Inc. | 1.41 Million USD | -324995.113% |
| Coeptis Therapeutics Holdings, Inc. | -244.9 Thousand USD | 1874413.211% |
| Vanda Pharmaceuticals Inc. | -126.41 Million USD | 3731.112% |
| Lexaria Bioscience Corp. | -1.18 Million USD | 386448.605% |
| Portage Biotech Inc. | -4.98 Million USD | 92257.057% |
| Cardio Diagnostics Holdings, Inc. | -22.49 Thousand USD | 20406159.124% |
| Olema Pharmaceuticals, Inc. | -66.12 Million USD | 7042.233% |
| OncoCyte Corporation | -6.56 Million USD | 70042.755% |
| Qualigen Therapeutics, Inc. | 897.41 Thousand USD | -511408.414% |
| Processa Pharmaceuticals, Inc. | -4.55 Million USD | 100861.693% |
| Purple Biotech Ltd. | -14.13 Million USD | 32568.121% |
| CollPlant Biotechnologies Ltd. | -23.75 Million USD | 19422.878% |
| scPharmaceuticals Inc. | -6.54 Million USD | 70235.111% |
| ProMIS Neurosciences, Inc. | -16.69 Million USD | 27599.986% |
| HilleVax, Inc. | -165.48 Million USD | 2873.873% |
| NeuroSense Therapeutics Ltd. | -2.53 Million USD | 180964.578% |
| Tharimmune, Inc. | -10.93 Million USD | 42077.094% |
| Genprex, Inc. | -6.73 Million USD | 68229.946% |
| Neumora Therapeutics, Inc. Common Stock | -368.8 Million USD | 1344.646% |
| Atossa Therapeutics, Inc. | -88.46 Million USD | 5289.174% |
| XTL Biopharmaceuticals Ltd. | -1.4 Million USD | 327747.609% |
| Virios Therapeutics, Inc. | -3.31 Million USD | 138490.646% |
| OKYO Pharma Limited | -826.84 Thousand USD | 555261.65% |
| Savara Inc. | 153 Thousand USD | -3000124.183% |
| Curis, Inc. | -23.88 Million USD | 19316.909% |
| Daré Bioscience, Inc. | -5.15 Million USD | 89096.165% |
| Carmell Therapeutics Corporation | -776.01 Thousand USD | 591629.899% |
| Titan Pharmaceuticals, Inc. | -6.2 Million USD | 74042.381% |
| Achieve Life Sciences, Inc. | 1.18 Million USD | -387270.717% |
| BeiGene, Ltd. | -2.25 Billion USD | 303.736% |
| Kiromic BioPharma, Inc. | 12.33 Million USD | -37103.412% |
| Revolution Medicines, Inc. Warrant | -608.2 Million USD | 854.737% |
| Protagonist Therapeutics, Inc. | -185.58 Million USD | 2573.432% |
| Erasca, Inc. | -37.21 Million USD | 12434.327% |
| bluebird bio, Inc. | 108.57 Million USD | -4127.964% |
| Protagenic Therapeutics, Inc. | -1.28 Million USD | 356522.7% |
| BioMarin Pharmaceutical Inc. | 378.74 Million USD | -1111.978% |
| DBV Technologies S.A. | -126.98 Million USD | 3714.842% |
| Protagenic Therapeutics, Inc. | -1.28 Million USD | 356522.7% |
| Moderna, Inc. | -2.9 Billion USD | 257.907% |
| Vincerx Pharma, Inc. | -10.35 Million USD | 44442.571% |
| Fresh Tracks Therapeutics, Inc. | -10.86 Million USD | 42337.238% |
| Molecular Templates, Inc. | 707 Thousand USD | -649170.58% |
| Acrivon Therapeutics, Inc. Common Stock | -31.37 Million USD | 14732.441% |
| Travere Therapeutics, Inc. | 346.6 Million USD | -1224.362% |
| Monte Rosa Therapeutics, Inc. | -82.06 Million USD | 5693.75% |
| Spruce Biosciences, Inc. | -91.73 Million USD | 5104.189% |
| Celldex Therapeutics, Inc. | -32.27 Million USD | 14323.919% |
| Cogent Biosciences, Inc. | -34.37 Million USD | 13453.337% |
| MacroGenics, Inc. | -66.98 Million USD | 6952.792% |
| RenovoRx, Inc. | -1.17 Million USD | 391433.589% |
| Adicet Bio, Inc. | -138.78 Million USD | 3407.473% |
| Prime Medicine, Inc. | -27.94 Million USD | 16528.7% |
| Aditxt, Inc. | 18.12 Million USD | -25231.782% |
| Adagene Inc. | -87.62 Million USD | 5338.48% |
| Estrella Immunopharma, Inc. | -4.16 Million USD | 110300.993% |
| Quantum-Si incorporated | -118.55 Million USD | 3971.845% |
| Maravai LifeSciences Holdings, Inc. | 36 Million USD | -12649.182% |
| Acurx Pharmaceuticals, Inc. | -7.47 Million USD | 61515.942% |
| Voyager Therapeutics, Inc. | -48.5 Million USD | 9562.869% |
| SciSparc Ltd. | -2.06 Million USD | 222392.639% |
| Vericel Corporation | 1.27 Million USD | -359363.038% |
| Revelation Biosciences, Inc. | -11.99 Million USD | 38379.332% |
| Minerva Neurosciences, Inc. | 41 Million USD | -11094.799% |
| Generation Bio Co. | 31.44 Million USD | -14496.613% |
| Astria Therapeutics, Inc. | -175.36 Million USD | 2717.609% |
| Black Diamond Therapeutics, Inc. | -30.92 Million USD | 14944.43% |
| Arcutis Biotherapeutics, Inc. | 116.59 Million USD | -3837.066% |
| Invivyd, Inc. | -198.47 Million USD | 2412.795% |
| Relay Therapeutics, Inc. | -90.27 Million USD | 5185.126% |
| Quoin Pharmaceuticals, Ltd. | -2.39 Million USD | 191548.699% |
| Spero Therapeutics, Inc. | -70.79 Million USD | 6584.451% |
| Artelo Biosciences, Inc. | -6.82 Million USD | 67357.773% |
| 2seventy bio, Inc. | 181.71 Million USD | -2426.122% |
| ADMA Biologics, Inc. | 90.06 Million USD | -4996.644% |
| Clene Inc. | 3.34 Million USD | -137335.419% |
| Capricor Therapeutics, Inc. | -9.08 Million USD | 50639.393% |
| Boundless Bio, Inc. Common Stock | -21.51 Million USD | 21439.515% |
| GeoVax Labs, Inc. | -6.45 Million USD | 71239.553% |
| Recursion Pharmaceuticals, Inc. | -344.12 Million USD | 1433.921% |
| Citius Pharmaceuticals, Inc. | -25.99 Million USD | 17755.381% |
| Contineum Therapeutics, Inc. Class A Common Stock | 177.66 Million USD | -2483.692% |
| Relmada Therapeutics, Inc. | -4.09 Million USD | 112290.342% |
| Finch Therapeutics Group, Inc. | 5 Million USD | -91670.152% |
| ALX Oncology Holdings Inc. | -5.2 Million USD | 88223.306% |
| Vir Biotechnology, Inc. | -130.3 Million USD | 3622.795% |
| Evaxion Biotech A/S | 5.28 Million USD | -86725.77% |
| Ocular Therapeutix, Inc. | -112.56 Million USD | 4177.84% |
| Verve Therapeutics, Inc. | -131.27 Million USD | 3596.791% |
| Trevena, Inc. | 2.25 Million USD | -203192.427% |
| Surrozen, Inc. | -32.66 Million USD | 14153.218% |
| Tyra Biosciences, Inc. | -51.51 Million USD | 9011.557% |
| Cingulate Inc. | 3.08 Million USD | -148807.397% |
| Galmed Pharmaceuticals Ltd. | -2.93 Million USD | 156393.599% |
| Unity Biotechnology, Inc. | 7.18 Million USD | -63770.085% |
| Tenax Therapeutics, Inc. | -9.29 Million USD | 49505.132% |
| Terns Pharmaceuticals, Inc. | -79.32 Million USD | 5886.9% |
| ACADIA Pharmaceuticals Inc. | -131.45 Million USD | 3592.03% |
| Connect Biopharma Holdings Limited | -105.54 Million USD | 4449.305% |
| Clearmind Medicine Inc. | -3.94 Million USD | 116528.243% |
| Kronos Bio, Inc. | -36.05 Million USD | 12831.855% |
| Bolt Biotherapeutics, Inc. | 9.4 Million USD | -48686.725% |
| CERo Therapeutics Holdings, Inc. | 1.45 Million USD | -314710.918% |
| Viking Therapeutics, Inc. | -54.25 Million USD | 8560.526% |
| Statera Biopharma, Inc. | 14.41 Million USD | -31741.105% |
| ImmunityBio, Inc. | 618.22 Million USD | -642.505% |
| Korro Bio, Inc. | -132.94 Million USD | 3552.866% |
| Kineta, Inc. | -4.54 Million USD | 101186.611% |
| BioVie Inc. | -17.73 Million USD | 25986.827% |
| Codexis, Inc. | -43.27 Million USD | 10708.359% |
| Celularity Inc. | 65.19 Million USD | -6941.483% |
| Crinetics Pharmaceuticals, Inc. | -3.16 Million USD | 144951.467% |
| Celcuity Inc. | 6.78 Million USD | -67569.152% |
| Virax Biolabs Group Limited | -3.36 Million USD | 136516.624% |
| Cibus, Inc. | -8.07 Million USD | 56925.241% |
| Eledon Pharmaceuticals, Inc. | -4.22 Million USD | 108644.408% |
| eFFECTOR Therapeutics, Inc. | 4.57 Million USD | -100345.142% |
| IN8bio, Inc. | -16.38 Million USD | 28108.683% |
| Kodiak Sciences Inc. | -103.87 Million USD | 4519.103% |
| Annexon, Inc. | -193.75 Million USD | 2469.148% |
| Adverum Biotechnologies, Inc. | 36 Thousand USD | -12750852.778% |
| Assembly Biosciences, Inc. | -17.49 Million USD | 26332.03% |
| Avalo Therapeutics, Inc. | -3.51 Million USD | 130767.321% |
| Ionis Pharmaceuticals, Inc. | 1.05 Billion USD | -335.404% |
| Eyenovia, Inc. | 1.25 Million USD | -364588.624% |
| Puma Biotechnology, Inc. | 26.9 Million USD | -16961.301% |
| Conduit Pharmaceuticals Inc. | -3.24 Million USD | 141646.192% |
| Xilio Therapeutics, Inc. | -33.24 Million USD | 13906.789% |
| Arcellx, Inc. | -296.95 Million USD | 1645.789% |
| Cardiff Oncology, Inc. | -19.5 Million USD | 23632.98% |
| Enanta Pharmaceuticals, Inc. | -58.87 Million USD | 7896.761% |
| Regulus Therapeutics Inc. | -20.72 Million USD | 22246.683% |
| Moolec Science SA | 117.61 Thousand USD | -3902721.895% |
| Acumen Pharmaceuticals, Inc. | -38.39 Million USD | 12054.33% |
| Geron Corporation | 14.76 Million USD | -30997.778% |
| LAVA Therapeutics N.V. | -37.91 Million USD | 12205.973% |
| Royalty Pharma plc | 5.65 Billion USD | 18.874% |
| Atea Pharmaceuticals, Inc. | -141.42 Million USD | 3345.871% |
| Greenwich LifeSciences, Inc. | -6.98 Million USD | 65775.555% |
| TFF Pharmaceuticals, Inc. | -5.36 Million USD | 85695.072% |
| Mersana Therapeutics, Inc. | -140.73 Million USD | 3361.785% |
| Humacyte, Inc. | -22.48 Million USD | 20514.227% |
| Structure Therapeutics Inc. | -124.33 Million USD | 3791.796% |
| 89bio, Inc. | -289.05 Million USD | 1688.063% |
| PMV Pharmaceuticals, Inc. | -25.24 Million USD | 18285.338% |
| Avenue Therapeutics, Inc. | -1.78 Million USD | 257550.533% |
| Genelux Corporation | -6.89 Million USD | 66636.353% |
| Trevi Therapeutics, Inc. | -31.05 Million USD | 14879.429% |
| Lexicon Pharmaceuticals, Inc. | 83.59 Million USD | -5390.907% |
| Notable Labs, Ltd. | -9.77 Million USD | 47055.227% |
| Liquidia Corporation | -80.17 Million USD | 5825.333% |
| Mustang Bio, Inc. | -3.73 Million USD | 122967.853% |
| Immunovant, Inc. | -635.22 Million USD | 822.63% |
| Quantum-Si incorporated | -118.55 Million USD | 3971.845% |
| Arbutus Biopharma Corporation | -17.56 Million USD | 26234.952% |
| DiaMedica Therapeutics Inc. | -4.14 Million USD | 110897.562% |
| Vera Therapeutics, Inc. | 8.02 Million USD | -57086.284% |
| Acasti Pharma Inc. | -23 Million USD | 20053.675% |
| MiNK Therapeutics, Inc. | -3.36 Million USD | 136424.052% |
| Pasithea Therapeutics Corp. | -16.24 Million USD | 28349.356% |
| Xenon Pharmaceuticals Inc. | -137.74 Million USD | 3432.614% |
| Elevai Labs, Inc. Common Stock | -3.11 Million USD | 147398.132% |
| NeuroBo Pharmaceuticals, Inc. | -22.23 Million USD | 20747.459% |
| Tempest Therapeutics, Inc. | -18.56 Million USD | 24820.464% |
| Soleno Therapeutics, Inc. | -169.27 Million USD | 2811.719% |
| PepGen Inc. | -60.67 Million USD | 7666.084% |
| Moleculin Biotech, Inc. | -22.97 Million USD | 20078.861% |
| United Therapeutics Corporation | -507.7 Million USD | 1004.145% |
| Nuvectis Pharma, Inc. | -19.12 Million USD | 24100.539% |
| Solid Biosciences Inc. | -47.75 Million USD | 9713.284% |
| BriaCell Therapeutics Corp. | -862.08 Thousand USD | 532567.413% |
| Immuneering Corporation | -54.94 Million USD | 8454.758% |
| Lixte Biotechnology Holdings, Inc. | -4.2 Million USD | 109303.19% |
| Silo Pharma, Inc. | -3.52 Million USD | 130348.066% |
| Belite Bio, Inc | -87.27 Million USD | 5359.872% |
| XOMA Corporation | -29 Million USD | 15928.769% |
| ARS Pharmaceuticals, Inc. | -70.69 Million USD | 6592.981% |
| Bionomics Limited | 227 Million USD | -1922.089% |
| Apogee Therapeutics, Inc. | -116.28 Million USD | 4047.595% |
| Alpha Tau Medical Ltd. | -2.53 Million USD | 181321.595% |
| uniQure N.V. | -102.95 Million USD | 4558.765% |
| Cassava Sciences, Inc. | -121.13 Million USD | 3889.413% |
| Estrella Immunopharma, Inc. | -4.16 Million USD | 110300.993% |
| Poseida Therapeutics, Inc. | 40.95 Million USD | -11109.355% |
| Forte Biosciences, Inc. | -11.96 Million USD | 38477.585% |
| Anebulo Pharmaceuticals, Inc. | -3.09 Million USD | 148453.145% |
| Enlivex Therapeutics Ltd. | 106 Thousand USD | -4330412.264% |
| Conduit Pharmaceuticals Inc. | -3.24 Million USD | 141646.192% |
| SeaStar Medical Holding Corporation | 8.9 Million USD | -51447.928% |
| FibroBiologics, Inc. Common Stock | -7.41 Million USD | 61997.829% |
| Altimmune, Inc. | -134.48 Million USD | 3513.224% |
| Amicus Therapeutics, Inc. | 198.06 Million USD | -2217.594% |
| Alpha Tau Medical Ltd. | -2.53 Million USD | 181321.595% |
| Compugen Ltd. | -12.9 Million USD | 35673.024% |
| Peak Bio, Inc. | 10.34 Million USD | -44293.355% |
| Zevra Therapeutics, Inc. | -283 Thousand USD | 1622129.329% |
| Benitec Biopharma Inc. | -50.58 Million USD | 9175.052% |
| Spyre Therapeutics, Inc. | -104.33 Million USD | 4499.493% |
| NKGen Biotech, Inc. Common Stock | 19.64 Million USD | -23266.47% |
| Zura Bio Limited | -99.8 Million USD | 4699.266% |
| PolyPid Ltd. | 6.17 Million USD | -74297.78% |
| Aileron Therapeutics, Inc. | 74.12 Million USD | -6093.123% |
| NKGen Biotech, Inc. Warrants | 19.64 Million USD | -23266.47% |
| Instil Bio, Inc. | 75.35 Million USD | -5991.381% |
| argenx SE | -2.02 Billion USD | 326.254% |
| Immunome, Inc. | -97.02 Million USD | 4830.898% |
| Compass Therapeutics, Inc. | -22.49 Million USD | 20506.059% |
| Verona Pharma plc | -220.44 Million USD | 2182.326% |
| enGene Holdings Inc. Warrants | -71.74 Million USD | 6498.315% |
| Shattuck Labs, Inc. | -121.42 Million USD | 3880.425% |
| CervoMed Inc. | -7.79 Million USD | 59004.577% |
| LENZ Therapeutics, Inc. | -185.49 Million USD | 2574.592% |
| Plus Therapeutics, Inc. | -4.37 Million USD | 105070.112% |
| Dianthus Therapeutics, Inc. | -131.73 Million USD | 3584.396% |
| Moolec Science SA | 117.61 Thousand USD | -3902721.895% |
| Enveric Biosciences, Inc. | -2.28 Million USD | 200728.896% |
| Inovio Pharmaceuticals, Inc. | 15.89 Million USD | -28773.024% |
| AnaptysBio, Inc. | -18.15 Million USD | 25389.753% |
| Design Therapeutics, Inc. | -18.15 Million USD | 25391.146% |
| Leap Therapeutics, Inc. | -70.38 Million USD | 6622.134% |
| NeurAxis, Inc. | 145.7 Thousand USD | -3150444.269% |
| Seelos Therapeutics, Inc. | 11.23 Million USD | -40768.438% |
| Lumos Pharma, Inc. | -28.49 Million USD | 16210.424% |
| Achilles Therapeutics plc | -126.92 Million USD | 3716.608% |
| enGene Holdings Inc. Common Stock | -71.74 Million USD | 6498.315% |
| 180 Life Sciences Corp. | -655.73 Thousand USD | 700135.533% |
| Opiant Pharmaceuticals, Inc. | -20.77 Million USD | 22196.764% |
| CERo Therapeutics Holdings, Inc. | 1.45 Million USD | -314710.918% |
| Nutriband Inc. | -251.65 Thousand USD | 1824147.414% |
| ORIC Pharmaceuticals, Inc. | -13.17 Million USD | 34951.894% |
| CG Oncology, Inc. Common stock | -7.44 Million USD | 61798.159% |
| Fractyl Health, Inc. Common Stock | 340.19 Million USD | -1249.319% |
| Rani Therapeutics Holdings, Inc. | 23.73 Million USD | -19239.975% |
| MoonLake Immunotherapeutics | -447.47 Million USD | 1125.84% |
| Palisade Bio, Inc. | -12.06 Million USD | 38153.08% |
| Tourmaline Bio, Inc. | -140.31 Million USD | 3371.549% |
| Beam Therapeutics Inc. | -262.72 Million USD | 1847.224% |
| Neurogene Inc. | -131.95 Million USD | 3578.719% |
| Mirum Pharmaceuticals, Inc. | 21.81 Million USD | -20941.176% |
| AEON Biopharma, Inc. | -4.88 Million USD | 94164.406% |
| CARGO Therapeutics, Inc. Common Stock | -377.19 Million USD | 1316.981% |
| Sesen Bio, Inc. | -112.55 Million USD | 4178.384% |
| Enliven Therapeutics, Inc. | -99.86 Million USD | 4696.778% |
| Kiora Pharmaceuticals, Inc. | -2.34 Million USD | 195617.365% |
| Iovance Biotherapeutics, Inc. | -39.02 Million USD | 11862.269% |
| Taysha Gene Therapies, Inc. | -83.28 Million USD | 5611.807% |
| Athira Pharma, Inc. | -88.99 Million USD | 5257.747% |
| Vaccinex, Inc. | -1.28 Million USD | 356493.09% |
| HCW Biologics Inc. | 2.85 Million USD | -160588.261% |
| XOMA Corporation | -29 Million USD | 15928.769% |
| Nektar Therapeutics | 210.24 Million USD | -2083.382% |
| Arvinas, Inc. | -313.8 Million USD | 1562.824% |
| Tevogen Bio Holdings Inc. | 1.62 Million USD | -282749.916% |
| Merus N.V. | -192.88 Million USD | 2479.846% |
| Omega Therapeutics, Inc. | 59.98 Million USD | -7552.485% |
| Quince Therapeutics, Inc. | -6.93 Million USD | 66262.338% |
| Rezolute, Inc. | -68.16 Million USD | 6833.868% |
| Clene Inc. | 3.34 Million USD | -137335.419% |
| Indaptus Therapeutics, Inc. | -13.18 Million USD | 34909.608% |
| BeyondSpring Inc. | -13.75 Million USD | 33472.177% |
| Synlogic, Inc. | -6.68 Million USD | 68766.313% |
| Allarity Therapeutics, Inc. | 1.13 Million USD | -404692.152% |
| Phio Pharmaceuticals Corp. | -8.45 Million USD | 54391.461% |
| Peak Bio, Inc. | 10.34 Million USD | -44293.355% |
| Werewolf Therapeutics, Inc. | -82.42 Million USD | 5669.453% |
| Krystal Biotech, Inc. | -350.23 Million USD | 1410.65% |
| Karyopharm Therapeutics Inc. | 124.12 Million USD | -3598.162% |
| SpringWorks Therapeutics, Inc. | -168.99 Million USD | 2816.244% |
| Lipella Pharmaceuticals Inc. | -3.15 Million USD | 145495.427% |
| MannKind Corporation | 143.89 Million USD | -3089.976% |
| Ikena Oncology, Inc. | -109.15 Million USD | 4305.305% |
| Cyclerion Therapeutics, Inc. | -7.57 Million USD | 60730.604% |
| Gyre Therapeutics, Inc. | -33.1 Million USD | 13968.106% |
| Gossamer Bio, Inc. | 180.35 Million USD | -2445.171% |
| CohBar, Inc. | -5.93 Million USD | 77499.278% |
| Cognition Therapeutics, Inc. | -29.74 Million USD | 15530.762% |
| NRx Pharmaceuticals, Inc. | 4.56 Million USD | -100433.136% |
| Legend Biotech Corporation | -949.39 Million USD | 583.5% |
| Mural Oncology plc | -255.84 Million USD | 1894.203% |
| Biora Therapeutics, Inc. | 32.21 Million USD | -14149.086% |
| PaxMedica, Inc. Common Stock | -4.71 Million USD | 97546.229% |
| Disc Medicine, Inc. | -358.28 Million USD | 1381.213% |
| Champions Oncology, Inc. | 4.81 Million USD | -95293.662% |
| REGENXBIO Inc. | 54.76 Million USD | -8281.433% |
| Ensysce Biosciences, Inc. | -268.9 Thousand USD | 1707137.377% |
| Anavex Life Sciences Corp. | -151.02 Million USD | 3139.479% |
| Cellectar Biosciences, Inc. | -9.01 Million USD | 51035.863% |
| Edgewise Therapeutics, Inc. | -80.68 Million USD | 5789.356% |
| Vaxart, Inc. | -8.24 Million USD | 55801.286% |
| PharmaCyte Biotech, Inc. | -50.17 Million USD | 9247.76% |
| Aldeyra Therapeutics, Inc. | -127.16 Million USD | 3709.735% |
| Cellectis S.A. | -43.85 Million USD | 10567.092% |
| Longeveron Inc. | -2.9 Million USD | 157952.235% |
| Repare Therapeutics Inc. | -107.85 Million USD | 4355.913% |
| Sarepta Therapeutics, Inc. | 968.37 Million USD | -374.024% |
| Inozyme Pharma, Inc. | 12 Million USD | -38140.112% |
| Revolution Medicines, Inc. | -608.2 Million USD | 854.737% |
| Nymox Pharmaceutical Corporation | -1.23 Million USD | 373298.618% |
| Third Harmonic Bio, Inc. | -265.11 Million USD | 1831.44% |
| ArriVent BioPharma, Inc. Common Stock | -150.07 Million USD | 3158.76% |
| AN2 Therapeutics, Inc. | -15.64 Million USD | 29436.889% |
| Anixa Biosciences, Inc. | -740 Thousand USD | 620416.622% |
| Vertex Pharmaceuticals Incorporated | -9.56 Billion USD | 147.997% |
| Denali Therapeutics Inc. | -74.86 Million USD | 6231.494% |
| Revelation Biosciences, Inc. | -11.99 Million USD | 38379.332% |
| Veru Inc. | 4.77 Million USD | -95932.903% |
| Corvus Pharmaceuticals, Inc. | -11.24 Million USD | 40917.562% |
| Cingulate Inc. | 3.08 Million USD | -148807.397% |
| Passage Bio, Inc. | 4.58 Million USD | -100016.532% |
| Context Therapeutics Inc. | -14.44 Million USD | 31867.46% |
| Exicure, Inc. | 5.84 Million USD | -78380.817% |
| Day One Biopharmaceuticals, Inc. | -230.37 Million USD | 2092.544% |
| Oramed Pharmaceuticals Inc. | -39.57 Million USD | 11700.564% |
| Scinai Immunotherapeutics Ltd. | 15.69 Million USD | -29154.624% |
| Rhythm Pharmaceuticals, Inc. | -58.82 Million USD | 7903.919% |
| Nuvalent, Inc. | -335.38 Million USD | 1468.671% |
| ABVC BioPharma, Inc. | 1.73 Million USD | -264573.614% |
| Carisma Therapeutics, Inc. | -74.48 Million USD | 6263.023% |
| Unicycive Therapeutics, Inc. | -8.89 Million USD | 51734.904% |
| OmniAb, Inc. | 9.2 Million USD | -49778.768% |
| Anew Medical, Inc. | 1.43 Million USD | -320350.622% |
| Fennec Pharmaceuticals Inc. | 16.38 Million USD | -27921.07% |
| Lipocine Inc. | -4.75 Million USD | 96645.466% |
| Lexeo Therapeutics, Inc. Common Stock | -109.82 Million USD | 4279.574% |
| Nautilus Biotechnology, Inc. | 15.23 Million USD | -30038.159% |
| SAB Biotherapeutics, Inc. | -50.65 Million USD | 9161.257% |
| G1 Therapeutics, Inc. | 24.89 Million USD | -18341.037% |
| Bellerophon Therapeutics, Inc. | -6.72 Million USD | 68398.512% |
| Sage Therapeutics, Inc. | -65.82 Million USD | 7073.344% |
| Ocugen, Inc. | -32.52 Million USD | 14215.012% |
| Mind Medicine (MindMed) Inc. | -85.57 Million USD | 5464.117% |
| Q32 Bio Inc. | -37.94 Million USD | 12196.403% |
| Brainstorm Cell Therapeutics Inc. | -628 Thousand USD | 731046.338% |
| Alumis Inc. Common Stock | -13.52 Million USD | 34029.655% |
| Equillium, Inc. | -22.39 Million USD | 20599.924% |
| Kyverna Therapeutics, Inc. | -25.56 Million USD | 18053.469% |
| Coya Therapeutics, Inc. | -32.62 Million USD | 14169.254% |
| CNS Pharmaceuticals, Inc. | -247.91 Thousand USD | 1851679.372% |
| Galera Therapeutics, Inc. | 134.04 Million USD | -3324.556% |
| Evelo Biosciences, Inc. | 3.19 Million USD | -143437.93% |
| Comera Life Sciences Holdings, Inc. | 328.44 Thousand USD | -1397515.706% |
| Dominari Holdings Inc. | 195 Thousand USD | -2353922.051% |
| Edesa Biotech, Inc. | -5.26 Million USD | 87254.385% |
| vTv Therapeutics Inc. | -8.91 Million USD | 51578.558% |
| Bio-Techne Corporation | 267.74 Million USD | -1614.433% |
| Agios Pharmaceuticals, Inc. | -16.2 Million USD | 28419.717% |
| Harmony Biosciences Holdings, Inc. | -118.09 Million USD | 3987.025% |
| Prelude Therapeutics Incorporated | -8.4 Million USD | 54727.431% |
| Candel Therapeutics, Inc. | -12.65 Million USD | 36384.428% |
| iTeos Therapeutics, Inc. | -245.11 Million USD | 1972.7% |
| Nkarta, Inc. | 57.29 Million USD | -7911.21% |
| BioCardia, Inc. | 212 Thousand USD | -2165156.132% |
| Iterum Therapeutics plc | 13.43 Million USD | -34059.421% |